Drug Index

Rifabutin

 
print

Mechanism :

Rifabutin acts via the inhibition of DNA-dependent RNA polymerase in gram-positive and some gram-negative bacteria, leading to a suppression of RNA synthesis and cell death.


Indication :

• Mycobacterium Avium Complex (MAC) infection in HIV infected.

• Treatment of tuberculosis (TB) due to mycobacterium tuberculosis (MTB) as an alternative to rifampin in combination with other antitubercular agents.


Contraindications :

Hypersensitivity, Active TB; Caution if neutropenia, thrombocytopenia.


Dosing :

MAC prophylaxis:

5 mg/kg PO OD. Max: 300 mg/day.

Treatment of MAC disseminated:

10-20 mg/kg/day PO OD. Max: 300 mg/day.

Treatment of TB due to MTB as an alternative to rifampicin:

10 to 20 mg/kg/dose PO once daily. Max: 300 mg/day.

With concomitant protease inhibitors or concomitant cobicistat, elvitegravir, emtricitabine or tenofovir give half the dose (Max: 150 mg/day or 300 mg 3 times a week). With concomitant efavirenz, increase the dose by 1½-2 times. Max: 450 to 600 mg PO once daily.


Adverse Effect :

Neutropenia, leukopenia, thrombocytopenia, uveitis, Clostridium difficile associated diarrhea, orange colour urine, rash, nausea, abdominal pain, headache, dyspepsia, diarrhea, eructation, vomiting, taste changes, fever, anorexia, flatulence, myalgia, asthenia, chest pain, insomnia, yellow skin.


Interaction :

Abiraterone, Acenocoumarol: Rifabutin may decrease the anticoagulant effect
Amitriptyline, Amoxapine: The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant.
Amprenavir: Amprenavir may increase the effect and toxicity of rifabutin.
Atovaquone: Rifabutin decreases the effect of atovaquone.
Indinavir: Rifabutin decreases the effect of indinavir.
Itraconazole: Rifabutin decreases the effect of itraconazole.
Ivacaftor: Strong CYP3A4 inducers may decrease levels of ivacaftor.
Josamycin: The rifamycin, rifabutin, may decrease the effect of the macrolide, josamycin.
Lovastatin: Rifabutin may decrease the effect of lovastatin by increasing its metabolism.
Mestranol: This product may cause a slight decrease of the contraceptive effect.
Methadone: The rifamycin decreases the effect of methadone.
Norethindrone: Rifabutin may decrease the contraceptive effect of norethindrone.
Nortriptyline: The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, nortriptyline, by increasing its metabolism.
Pazopanib: Affects CYP3A4 metabolism therefore will decrease levels or effect of pazopanib.
Posaconazole: Modification of drug levels for both agents.
Propafenone: Rifampin decreases the effect of propafenone.
Protriptyline: The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, protriptyline, by increasing its metabolism.
Rilpivirine: Strong inducers of CYP3A4 decrease the exposure of rilpivirine thus decreasing efficacy.
Ritonavir: Rifabutin decreases the effect of ritonavir.
Roflumilast: Affects CYP3A4 metabolism, decreases level or effect of roflumilast.
Saquinavir: Rifabutin decreases the effect of saquinavir.
Simvastatin: Rifabutin may decrease the effect of simvastatin by increasing its metabolism.
Sirolimus: The rifamycin decreases the effect of sirolimus.
Sunitinib: Possible decrease in sunitinib levels.
Tacrolimus: Carbamazepine may decrease the blood concentration of Tacrolimus.
Tamoxifen: The rifamycin decreases the effect of anti-estrogen.
Telithromycin: Rifabutin may decrease the plasma concentration of Telithromycin.
Temsirolimus: Rifabutin may increase the metabolism of Temsirolimus decreasing its efficacy.
Terbinafine: Rifabutin may increase the metabolism and clearance of Terbinafine.
Tipranavir: Tipranavir increases the concentration of Rifabutin.
Tolvaptan: Rifabutin is a CYP3A4 inducer and will decrease serum concentrations of tolvaptan and ultimately, its clinical effects.
Toremifene: The rifamycin decreases the effect of anti-estrogen.
Tramadol: Rifabutin may decrease the effect of Tramadol by increasing Tramadol metabolism and clearance.
Trazodone: The CYP3A4 inducer, Rifabutin, may decrease Trazodone efficacy by increasing Trazodone metabolism and clearance.
Trimipramine: The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, trimipramine, by increasing its metabolism.
Vemurafenib: Strong CYP3A4 inducers may decrease levels of vemurafenib.
Verapamil, Voriconazole: Rifabutin may decrease the serum concentration of voriconazole. Voriconazole: may increase the serum concentration of rifabutin.
Warfarin: Rifabutin may decrease the anticoagulant effect of warfarin.


07/18/2019 11:51:11 Rifabutin
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0